Severe CD4+T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,832

Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

Autran, B., Carcelain, G., Li, T., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,786

Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404

Immune control of HIV-1 after early treatment of acute infection

Rosenberg, E. S., Altfeld, M. A., Poon, S. H. T., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D’Aquila, R. T., Goulder, P., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002

Programmed Death of T Cells in HIV-1 Infection

Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R., & Miedema, F. F. (1992) · Science · doi:10.1126/science.1352911 · Cited by 898

POPULATION BIOLOGY OF HIV-1 INFECTION: Viral and CD4 + T Cell Demographics and Dynamics in Lymphatic Tissues

Haase, A. T. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.625 · Cited by 541

Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis

Ameisen, J. C., & Capron, A. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90092-8 · Cited by 527

Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G 2 checkpoints

Zhao, H., Watkins, J. L., & Piwnica-Worms, H. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 472

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

Lederman, M. M., Connick, E., LANDAY, A. L., Kuritzkes, D. R., Spritzler, J., Clair, M. S., Kotzin, B. L., Fox, L. L., Heath-Chiozzi, M. E., Leonard, J. M., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515591 · Cited by 425

Overview of the Mucosal Immune System

Brandtzaeg, P. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74529-4_2 · Cited by 274

Wireless capsule endoscopy for the detection of small bowel diseases in HIV-1-infected patients

Oette, M., Stelzer, A., Göbels, K., Wettstein, M., Sagir, A., Feldt, T., & Häussinger, D. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-5-191 · Cited by 8

Pediatric HIV Infection

Mirza, A., & Rathore, M. H. (2012) · Advances in Pediatrics · doi:10.1016/j.yapd.2012.04.012 · Cited by 8

Estrategias de curación de la infección por VIH

Rodríguez-Muñoz, J., & Moreno, S. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.01.007 · Cited by 8

Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success, and failure

McCausland, M. R., Cruz-Lebrón, A., Pilch-Cooper, H. A., Howell, S. J., Albert, J. M., Park, Y. S., & Levine, A. D. (2020) · AIDS · doi:10.1097/qad.0000000000002499 · Cited by 8

Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A

Gabriel, E. M., Salinas, T. R. W., Gosselin, A., Larouche-Anctil, E., Durand, M., LANDAY, A. L., Far, M. E., Tremblay, C. L., Routy, J., & Ancuța, P. (2021) · AIDS · doi:10.1097/qad.0000000000002972 · Cited by 8

How does HIV impact on non-AIDS events in the era of HAART?

Barber, T., Hughes, A., Dinsmore, W. W., & Phillips, A. N. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008302 · Cited by 8

Gastrointestinal germinal center B cell depletion and reduction in IgA + plasma cells in HIV-1 infection

Cossarini, F., Shang, J., Krek, A., Al-Taie, Z., Hou, R., Canales-Herrerías, P., Tokuyama, M. A., Tankelevich, M., Tillowitz, A., Jha, D., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ado0090 · Cited by 7

Strategies for the cure of HIV infection

Rodríguez-Muñoz, J., & Moreno, S. (2019) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2019.02.001 · Cited by 7

Compromised Gut Associated Lymphoid Tissue is a Risk Factor for Postoperative Septic Complications in HIV‐Seropositive Trauma Patients

Mauser, M., Kruger, D., Pather, S., & Plani, F. (2021) · World Journal of Surgery · doi:10.1007/s00268-020-05899-z · Cited by 7

CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue

Augustin, M., Horn, C., Ercanoglu, M. S., de Silva, U. S., Bondet, V., Suárez, I., Chon, S., Nierhoff, D., Knops, E., Heger, E., et al. (2022) · Pathogens · doi:10.3390/pathogens11040483 · Cited by 7

Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals

Akusjärvi, S. S., Krishnan, S., Jütte, B. B., Ambikan, A. T., Gupta, S., Murillo, J. R., Végvári, Á., Sperk, M., Nowak, P., Vesterbacka, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03315-x · Cited by 7

The activation and dynamics of cytokine expression by CD4+ T cells and AIDS progression in HIV-1-infected Chinese individuals

Li, Y., Ling, W., Xu, H., Wang, M., & Wu, C. Y. (2012) · Microbial Pathogenesis · doi:10.1016/j.micpath.2012.07.008 · Cited by 7

Replication-Independent Expression of Anti-Apoptosis Marker Genes in Human Peripheral Blood Mononuclear Cells Infected with the Wild-Type HIV-1 and Reverse Transcriptase Variants

Sharma, P. L., Chunduri, H., Wise, J. L., Mindley, R., & Rimland, D. (2012) · Viral Immunology · doi:10.1089/vim.2011.0057 · Cited by 7

Antiretroviral therapy for HIV

Pozniak, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00043-9 · Cited by 8

Acute HIV-1 infection presenting with fulminant encephalopathy

Lee, E. J., Kim, Y. H., Lee, J. Y., Sunwoo, J., Park, S. Y., & Kim, T. H. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462417693734 · Cited by 7

Emerging Concepts in the Immunopathogenesis

Douek, D. C., Roederer, M., & Koup, R. A. (2009) · Cited by 7

The experiences of caregivers looking after a child living with HIV and AIDS in rural Malawi

Nyando, M. (2014) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 7

HIV Infection and the Gut: Scarred for Life?

Read, S. W., & Sereti, I. (2008) · The Journal of Infectious Diseases · doi:10.1086/590113 · Cited by 7

Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat

Sued, O. G., & Grosso, T. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91814-5.00023-4 · Cited by 12

Immunological and Virological Benefits Resulted from Short-Course Treatment during Primary HIV Infection: A Meta-Analysis

Chen, J., Han, X., An, M., Liu, J., Xu, J., Geng, W., Ji, Y., & Shang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082461 · Cited by 6

HIV integration and T cell death: additional commentary

Cooper, A., Garcia, M. L., Petrovas, C., Yamamoto, T., Koup, R. A., & Nabel, G. J. (2013) · Retrovirology · doi:10.1186/1742-4690-10-150 · Cited by 8

Host Molecule Incorporation into HIV Virions, Potential Influences in HIV Pathogenesis

Muñoz, O., Banga, R., & Perreau, M. (2022) · Viruses · doi:10.3390/v14112523 · Cited by 6

Lack of IL‐7 and IL‐15 signaling affects interferon‐γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells

Isakov, D., Dzutsev, A. H., Berzofsky, J. A., & Belyakov, I. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201141453 · Cited by 6

Infection par le virus de l’immunodéficience humaine

Vergnon-Miszczycha, D., Lucht, F., Roblin, X., Pozzetto, B., Paul, S., & Bourlet, T. (2015) · médecine/sciences · doi:10.1051/medsci/20153112012 · Cited by 6

Immunopathogenesis of HIV Infection

Vicenzi, E., Alfano, M., Ghezzi, S., & Poli, G. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_7 · Cited by 6

Human Immunodeficiency Virus Infection

Patel, P., Raizes, E. G., & Broyles, L. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-55512-8.00031-4 · Cited by 8

A infecção por HIV – importância das fases iniciais e do diagnóstico precoce

Loreto, S., & Azevedo‐Pereira, J. M. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 6

Frequency of Effector Memory Cells Expressing Integrin α4β7 Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4+ T Cell Count

Kasarpalkar, N., Bhowmick, S., Patel, V. V., Savardekar, L., Agrawal, S. R., Shastri, J. S., & Bhor, V. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651122 · Cited by 6

Treatment interruption to boost specific HIV immunity in acute infection

Kaufmann, D., & Walker, B. D. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3280119275 · Cited by 6

Infection versus immunity: What's the balance?

Shearer, W. T. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.06.001 · Cited by 6

Recent Advances in Nanoparticle-Based Antiretroviral Drug Delivery Systems for HIV Treatment and Prevention: A Comprehensive Review

Das, G., Shin, H., & Patra, J. K. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s540578 · Cited by 6

Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT ‐ SHIV infection with or without antiretroviral therapy

Ambrose, Z., Kline, C. E., Polacino, P. S., & Hu, S. (2014) · Journal of Medical Primatology · doi:10.1111/jmp.12126 · Cited by 5

Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4+ T Lymphocyte Depletion in Treated HIV Infection

Seang, S., Somasunderam, A., Nigalye, M., Somsouk, M., Schacker, T. W., Sanchez, J. L., Hunt, P. W., Utay, N. S., & Lake, J. E. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i2.180 · Cited by 5

HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells

Ickler, J., Francois, S., Widera, M., Santiago, M. L., Dittmer, U., & Sutter, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0218905 · Cited by 5

Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years

Davy-Méndez, T., Napravnik, S., Eron, J. J., Cole, S. R., van Duin, D., Wohl, D. A., Hogan, B., Althoff, K. N., Gebo, K. A., Moore, R. D., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa786 · Cited by 5

Diverse Mucosal-Associated Invariant TCR Usage in HIV Infection

Trivedi, S., Afroz, T., Bennett, M. S., Angell, K., Barros, F., Nell, R. A., Ying, J., Spivak, A. M., & Leung, D. T. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100026 · Cited by 5

Intestinal endothelial cells increase HIV infection and latency in resting and activated CD4 + T cells, particularly affecting CCR6 + CD4 + T cells

Eddy, J., Pham, F., Chee, R., Park, E., Dapprich, N., DeRuiter, S. L., & Shen, A. (2023) · Retrovirology · doi:10.1186/s12977-023-00621-y · Cited by 5

Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: A proof of concept study in macaques

Koopman, G., Beenhakker, N., Hofman, S., Walther–Jallow, L., Mäkitalo, B., Mooij, P., Anderson, J., Verschoor, E. J., Bogers, W. M. J. M., Heeney, J. L., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.082 · Cited by 5

A Decrease in Albumin in Early SIV Infection Is Related to Viral Pathogenicity

Graham, S. M., Holte, S., Kimata, J. T., Wener, M. H., & Overbaugh, J. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0267 · Cited by 5

HIV and Aging: Parallels and Synergistic Mechanisms Leading to Premature Disease and Functional Decline

Hearps, A. C., Schafer, K. R., High, K. P., & LANDAY, A. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_17 · Cited by 5

Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity

Chaudhary, O., Wang, L., Bose, D., Narayan, V., Yeh, M. T., Carville, A., Clements, J. D., Andino, R., Kozlowski, P. A., & Aldovini, A. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0157 · Cited by 5

Infection muqueuse par le virus VIH-1: mécanismes, conséquences, perspectives de vaccination

Lawrence, P., Zimmer, A., & Paul, S. (2009) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(09)71681-8 · Cited by 5

The therapeutic potential of RNA interference in controlling HIV-1 replication.

Soejitno, A., Wihandani, D. M., & Kuswardhani, T. (2009) · PubMed · Cited by 5

BACH2-driven tissue resident memory programs promote HIV-1 persistencePreprint

Wei, Y., Ma, H. K., Wong, M. E., Papasavvas, E., Konnikova, L., Tebas, P., Morgenstern, R., Montaner, L. J., & Ho, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628794 · Cited by 5

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Otte, F., Zhang, Y., Spagnuolo, J., Thielen, A., Däumer, M., Wiethe, C., Stoeckle, M., Kusejko, K., Klein, F., Metzner, K. J., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100485 · Cited by 4

Acute HIV Infection and ART Response: Insights into T Cell Subsets, Activation, Exhaustion, and Blood and GALT HIV Reservoir

de Moura, S. S., Caetano, D. G., Guimarães, M. L., da Silva, R. K. M., Cabral, N., Silva, S. D. C. C., Alves, M. R., Teixeira, S. L. M., Georg, I., dos Santos, D. V. G., et al. (2025) · Viruses · doi:10.3390/v17101381 · Cited by 4

Site‐specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV‐1?

Sasson, S. C., & Kelleher, A. D. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.12 · Cited by 4

A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics

Karris, M., Umlauf, A., Vaida, F., Richman, D. D., Little, S. J., & Smith, D. M. (2016) · Medicine · doi:10.1097/md.0000000000005315 · Cited by 4

γδ T cells mediate robust anti‐HIV functions during antiretroviral therapy regardless of immune checkpoint expression

Field, K. R., Wragg, K. M., Kent, S. J., Lee, W. S., & Juno, J. A. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1486 · Cited by 4

The Evolution of SIV in Primates and the Emergence of the Pathogen of AIDS

Greenwood, E. J. D., Schmidt, F., & Heeney, J. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7181-3_10 · Cited by 4

Exosomes Decrease In Vitro Infectivity of HIV-1 Preparations: Implication for CD4+T Lymphocyte Depletion In Vivo

Subra, C., Burelout, C., Sophie, P. B. F., Sebastien, S., & Gilbert, C. (2011) · InTech eBooks · doi:10.5772/19846 · Cited by 3

TRAIL protein localization in human primary T cells by 3D microscopy using 3D interactive surface plot: A new method to visualize plasma membrane

Gras, C., Smith, N., Sengmanivong, L., Gandini, M., Kubelka, C. F., & Herbeuval, J. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.10.008 · Cited by 4

Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections

Márquez-Coello, M., Arjona, M. M. D. O., Fernández-Gutiérrez, C., Ruiz-Sánchez, C., & González, J. A. G. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13201 · Cited by 4

Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

Lal, K. G., Phuang‐Ngern, Y., Suhkumvittaya, S., Leeansyah, E., Alrubayyi, A., Dias, J., Waickman, A. T., Kim, D., Kroon, E. D. M. B., Pinyakorn, S., et al. (2020) · Viruses · doi:10.3390/v12121426 · Cited by 4

Biological Aspects and Clinical Applications of Nanoparticles on Treatment and Prophylaxis of HIV

Saeedi, M., Mehranfar, F., Omidi, S. O., Ehsani, F. Z., & Pajand, O. (2020) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.14.6.512 · Cited by 4

α4β7high CD4+ T cells are prone to be infected by HIV‐1 and associated with HIV‐1 disease progression

Mijiti, Z., Song, J., Jiao, Y., Gao, L., Ma, H., Guo, X., Zhang, Q., Guo, Y., Ding, J., Zhang, S., et al. (2022) · HIV Medicine · doi:10.1111/hiv.13254 · Cited by 4

AIDS and HIV Infection after Thirty Years

Ippolito, G., Levy, J. A., Sönnerborg, A. B., Mugusi, F. M., & DIANZANI, F. (2013) · AIDS Research and Treatment · doi:10.1155/2013/731983 · Cited by 4

The Oral, Genital and Gut Microbiome in HIV Infection

Pérez‐Matute, P., Íñiguez, M., Villanueva-Millán, M. J., & Oteo, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00032-4 · Cited by 4

Gene Therapy Using RNAi

Yang, Y., Teng, W., & Yuan-Wei (2011) · InTech eBooks · doi:10.5772/19068 · Cited by 4

Thirty years on with an HIV epidemic in Zimbabwe (1985–2015)

Chingwaru, W., & Vidmar, J. (2015) · HIV & AIDS Review · doi:10.1016/j.hivar.2015.10.002 · Cited by 4

Wasting Disease, Chronic Immune Activation, and Inflammation in the HIV-Infected Patient

Wasserman, P., Segal‐Maurer, S., Wehbeh, W., & Rubin, D. S. (2011) · Topics in Clinical Nutrition · doi:10.1097/tin.0b013e318209e3a0 · Cited by 4

Mucosal Immune Regulation: Does it Help Thwart HIV?

Lajoie, J. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s7-006 · Cited by 4

Mucosal Macrophages in Defense and Regulation

Smythies, L. E., Denning, T. L., & Smith, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00026-4 · Cited by 4

HIV-Induced Apoptosis: Host Defense and Viral Strategy

Chisompola, D., Mwansa, P., Nzobokela, J., Ameka, M., Kirabo, A., Hinton, A. O., Jr., & Masenga, S. K. (2025) · Biology · doi:10.3390/biology14121680 · Cited by 5

Microbiota-derived 10-hydroxystearic acid activates PPARα to restore gut epithelial barrier integrity and enhance anti-retroviral therapy

Kramer, D., Rocha, C. S., Gaulke, C. A., Nearing, M., Sankaran‐Walters, S., Loque, I. C., Thyagatur, A., Pham, E. Q., Hu, S., Wanakumjorn, P., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02433-0 · Cited by 3

Nef Mutations in Long-term Non-progressors from Former Plasma Donors Infected with HIV-1 Subtype B in China

Wang, S., Xing, H., He, X., Zhu, F.-X., Zhe-Feng, M. E. N. G., Ruan, Y., & Shao, Y. (2008) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60007-6 · Cited by 3

Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/AIDS

Hu, S., Buser, E., Arredondo, J., Relyea, D., Rocha, C. S., & Dandekar, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.879152 · Cited by 3

The microbiome as a biomarker of anal precancerous lesions in people with HIV

Ron, R., Moreno, E., Cancio-Suárez, M. R., & Villar, S. S. (2023) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000985 · Cited by 3

Role and Future Applications of Extracellular Vesicles in HIV-1 Pathogenesis

Hubert, A., Barbeau, B., Subra, C., Bissonnette, L., & Gilbert, C. (2015) · Future Virology · doi:10.2217/fvl.15.11 · Cited by 3

Esophageal mucosa in HIV infection: A“deeper” look at this little spoken organ

Werneck–Silva, A. L., Pagliari, C., Patzina, R. A., Takakura, C. F. H., & Duarte, M. I. S. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13800 · Cited by 3

On high alert

Marris, E. (2010) · Nature · doi:10.1038/nature09234 · Cited by 3

Massive CD8 T Cell Response to Primary HIV Infection in the Setting of Severe Clinical Presentation

Arnoczy, G. S., Ferrari, G., Goonetilleke, N. P., Corrah, T., Li, H. J., Kuruc, J. D., Schmitz, J. L., McGee, K. S., Hicks, C. B., & Joseph J. Eron, A. T. C. F. H. V. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0145 · Cited by 3

Mucosal Immunopathogenesis of HIV Infection: Implications for Vaccine Development

Veazey, R. S. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.1.103 · Cited by 3

“Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy

De, W., Pollard, C., Vanham, G. L., & Rejm, J. (2012) · InTech eBooks · doi:10.5772/51583 · Cited by 3

Screening For Blood Transfusion Transmissible Viruses In Resource Limited Settings

(2011) · The Internet Journal of Infectious Diseases · doi:10.5580/132e · Cited by 3

The rationale for immunosuppressive therapy for HIV infection

Jacobson, J. M. (2007) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3280b01848 · Cited by 3

Detection of Feline Immunodeficiency Virus DNA Products in Lytic Versus Latent Infection, Including Early Reverse Transcription, Intermediate Reverse Transcription, and Late Circle Junctions

Sutton, S. (2007) · The Knowledge Bank (The Ohio State University) · Cited by 3

Gene Expression Profiling of HIV-1 Infection Using cDNA Microarrays

Wout, A. B. V. ’. (2005) · Humana Press eBooks · doi:10.1385/1-59259-907-9:455 · Cited by 3

In Silico Biology

Perrin, D., Ruskin, H. J., & Crane, M. (2010) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-60566-768-3.ch003 · Cited by 3

Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques

Hua, S., Benmeziane, K., Desjardins, D., Dimant, N., Léonec, M., Bossevot, L., Lemaître, J., Mélard, A., Relouzat, F., Avettand-Fènoël, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69848-5 · Cited by 2

Integrase strand-transfer inhibitors for treatment of early HIV infection

Teira, R., Gutiérrez, M. D. M., Galindo, P., Martínez, E., Muñoz, P., de la Fuente, B., Téllez, F., & Montero, M. (2019) · Medicine · doi:10.1097/md.0000000000016866 · Cited by 2

Nanotechnology and Its Implication in Antiviral Drug Delivery

Joshy, K. S., Snigdha, S., & Thomas, S. (2021) · Gels horizons: from science to smart materials · doi:10.1007/978-981-16-2119-2_8 · Cited by 2

Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4+ T cell infiltration is correlated with nadir but not current CD4+ T cell blood counts

Matsubara, Y., Ota, Y., Tanaka, Y., Denda, T., Hijikata, Y., Boku, N., Lim, L. A., Hirata, Y., Tsurita, G., Adachi, E., et al. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02188-8 · Cited by 2

Effects of Early Antiretroviral Therapy on the Composition and Diversity of the Fecal Microbiome of SIV-infected Rhesus Macaques (Macaca mulatta)

Lavinder, T., Fachko, D. N., Stanton, J., Varco-Merth, B. D., Smedley, J. V., Okoye, A. A., & Skalsky, R. L. (2022) · Comparative Medicine · doi:10.30802/aalas-cm-22-000020 · Cited by 2

Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4 + T Cells

Znaidia, M., de Souza-Angelo, Y., Létoffé, S., Staropoli, I., Grzelak, L., Ghigo, J., Schwartz, O., & Casartelli, N. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04313-22 · Cited by 2

Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection

Bennett, S. J., Davila, C. A., Reyes, Z., Valentín-Acevedo, A., Carrasco, K. G., Abadie, R., Marlin, M. C., Beel, M., Chapple, A. G., Fernando, S. C., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad045 · Cited by 2

Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV Cure

Cossarini, F., Aberg, J. A., Chen, B. K., & Mehandru, S. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0180 · Cited by 2

A Lower Viral Set Point but Little Immunological Impact After Early Treatment During Primary HIV Infection

Spits, H. B., Grijsen, M. L., Steingrover, R., Nanlohy, N. M., Kootstra, N. A., Borghans, J. A. M., van Baarle, D., Prins, J. M., & Schellens, I. M. M. (2015) · Viral Immunology · doi:10.1089/vim.2014.0094 · Cited by 2

La entrada viral como diana terapéutica. Situación actual de los inhibidores de la entrada

Arenzana‐Seisdedos, F. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76557-1 · Cited by 2

Infección por el virus de la inmunodeficiencia humana tipo 1 e inflamación persistente: ¿es la traslocación bacteriana la causa oculta?

Estébanez, M., Stella-Ascariz, N., & Bernardino, J. I. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2011.11.010 · Cited by 2

Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination

Shimada, M., Yoshizaki, S., Ichino, M., Klinman, D. M., & Okuda, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.046 · Cited by 2

Prime-Boost Vaccination: Impact on the HIV-1 Vaccine Field

Rose, R. D., Kent, S. J., & Ranasinghe, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416603-5.00012-2 · Cited by 2

B cell, CD8+ T cell and gamma delta T cell lymphocytic alveolitis alters alveolar immune cell homeostasis in HIV-infected Malawian adults

Mwale, A., Hummel, A., Mvaya, L., Kamng’ona, R., Chimbayo, E. T., Phiri, J., Malamba, R., Kankwatira, A., Mwandumba, H. C., & Jambo, K. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12869.1 · Cited by 2

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

Dunn, K. J., Rogers, R. S., Simonson, R. B., Luo, D., Sheng, S., Kassam, P. T., Seyedkazemi, S., & Hardy, H. (2021) · HIV Research & Clinical Practice · doi:10.1080/25787489.2021.1915652 · Cited by 2

Oral Vaccination Approaches for Anti-SHIV Immunity

de la Cruz, E. V., Wang, L., Bose, D., Gangadhara, S., Wilson, R. L., Amara, R. R., Kozlowski, P. A., & Aldovini, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702705 · Cited by 2

Impact of interplay between autophagy and interferon-alpha in HCV and HCV/HIV infection

LAJEVARDI, B., Bamdad, T., Choobin, H., Jamalidoust, M., & Namayandeh, M. (2019) · Acta Virologica · doi:10.4149/av_2019_214 · Cited by 2

Immune Responses to Mycobacterium tuberculosis and the Impact of HIV Infection

Riou, C., Stek, C. J., & Bruyn, E. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-29108-2_4 · Cited by 2

Noncoding RNA Expression During Viral Infection: The Long and the Short of It

Josset, L., Tisoncik-Go, J., & Katze, M. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-13689-9_6 · Cited by 2

Identification of Potential Drug Targets Using Genomics and Proteomics: A Systems Approach

Klase, Z. A., Duyne, R. V., & Kashanchi, F. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56011-4 · Cited by 2

Mucosa and vaccine-induced immune protection in nonhuman primates

Mattapallil, J. J., & Roederer, M. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282f9ae66 · Cited by 2

Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection

Guadalupe, M., Sankaran, S., George, M. D., Reay, E., Verhoeven, D. E., Shacklett, B. L., Flamm, J., Wegelin, J. A., Prindiville, T. P., & Dandekar, S. (2006) · Journal of Virology · doi:10.1128/jvi.00120-06 · Cited by 248

Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses

Macal, M., Sankaran, S., Chun, T.-W., Reay, E., Flamm, J., Prindiville, T., & Dandekar, S. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.35 · Cited by 195

Antiviral Therapy during Primary Simian Immunodeficiency Virus Infection Fails To Prevent Acute Loss of CD4 + T Cells in Gut Mucosa but Enhances Their Rapid Restoration through Central Memory T Cells

Verhoeven, D. E., Sankaran, S., Silvey, M., & Dandekar, S. (2008) · Journal of Virology · doi:10.1128/jvi.02164-07 · Cited by 67

Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection

Mehandru, S., Poles, M. A., Tenner‐Racz, K., Jean-Pierre, P., Manuelli, V., Lopez, P., Shet, A., Low, A., Mohri, H., Boden, D., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030484 · Cited by 287

Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4 � T Lymphocytes from Effector Sites in the Gastrointestinal Tract

Meh, S., Poles, M. A., Tenner‐Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Rácz, P., & Markowitz, M. H. (2004)